NCT06676033View on ClinicalTrials.gov

Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 18, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Leukemia, Chronic LymphocyticRichter Syndrome
Interventions
DRUG

epcoritamab

Samples from subjects receiving epcoritamab on another clinical trial GCT3013-03 will be collected.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH